Laboratory testing

Ended Purchase Order Awarded Last action

Contract number
75N91025P00119
Awardee
Awarding agency
Obligated
$14,800

Award facts

Contract value 100% obligated
$14,800.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This $14,800 firm fixed-price purchase order was awarded on December 28, 2024 by the National Cancer Institute, a civilian agency, to Leinco Technologies, Inc., a self-certified small disadvantaged business manufacturer of goods. The contract is for laboratory testing services and has a period of performance through December 27, 2025. Leinco Technologies has previously served as a subcontractor to Battelle Memorial Institute, providing specialized antibodies and reagents for SARS-CoV-1 and SARS-CoV-2 research, demonstrating its capabilities in producing critical materials to support viral research and vaccine development efforts. This contract award does not have a set-aside designation.

Quick answers

Who was awarded contract 75N91025P00119?

75N91025P00119 was awarded to Leinco Technologies, Inc. by National Cancer Institute (National Institutes of Health) on December 28, 2024.

How much is contract 75N91025P00119 worth?

The government has obligated $14,800 on 75N91025P00119.

Was contract 75N91025P00119 competed?

The extent of competition for 75N91025P00119 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login